Tobramycin Solution
Product Images NDC 70756-604

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 22 technical images submitted to the FDA as part of the official labeling for Tobramycin (NDC 70756-604). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lifestar Pharma Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Aaee88c2 4961 48e7 Aefb 86f1710bc60f 01)

Structure (Aaee88c2 4961 48e7 Aefb 86f1710bc60f 01)
Chemical structure of Tobramycin, a prescription drug used as an inhalation solution. The diagram shows the molecular arrangement typical of this aminoglycoside antibiotic.*
FDA Label Image

Figure 1: Relative Change From Baseline In Fev 1% Predicted (Aaee88c2 4961 48e7 Aefb 86f1710bc60f 02)

Figure 1: Relative Change From Baseline In Fev 1% Predicted (Aaee88c2 4961 48e7 Aefb 86f1710bc60f 02)
A line graph depicting average relative change in FEV1 % predicted over 24 weeks comparing Tobramycin Inhalation Solution (300 mg/5mL) from two studies versus placebo groups. The X-axis represents weeks with periods labeled 'on drug,' and the Y-axis shows percent change. Data lines include Study 1 and Study 2 for Tobramycin and placebo groups, indicating higher FEV1 improvements with Tobramycin inhalation solution.*
FDA Label Image

Figure 2: Absolute Change From Baseline In Log 10 Cfus (Aaee88c2 4961 48e7 Aefb 86f1710bc60f 03)

Figure 2: Absolute Change From Baseline In Log 10 Cfus (Aaee88c2 4961 48e7 Aefb 86f1710bc60f 03)
A line graph depicting the average change of log10 CFUs over a 24-week period for two studies comparing Tobramycin Inhalation Solution and placebo. The x-axis shows weeks, with indications of 'on drug' periods, and the y-axis shows the average change of log10 CFUs from -2.2 to 0.6. The graph includes data series for Study 1 and Study 2 for both placebo and Tobramycin treatment groups, showing a decrease in CFUs during treatment with Tobramycin compared to placebo.*
FDA Label Image

Instructions For Use Figure A (Aaee88c2 4961 48e7 Aefb 86f1710bc60f 04)

Instructions For Use Figure A (Aaee88c2 4961 48e7 Aefb 86f1710bc60f 04)
An instructional diagram illustrating the components of a Tobramycin inhalation solution nebulizer setup, including the air compressor, nebulizer cup, inspiratory valve cap, ampule of Tobramycin solution, mouthpiece, tubing, and clean paper or cloth towels surface.*
FDA Label Image

Instructions For Use Figure B (Aaee88c2 4961 48e7 Aefb 86f1710bc60f 05)

Instructions For Use Figure B (Aaee88c2 4961 48e7 Aefb 86f1710bc60f 05)
An instructional illustration showing hands twisting open a Tobramycin Inhalation Solution single-dose vial labeled 300 mg per 5 mL. The image demonstrates how to break the vial neck for respiratory inhalation use.*
FDA Label Image

Instructions For Use Figure C (Aaee88c2 4961 48e7 Aefb 86f1710bc60f 06)

Instructions For Use Figure C (Aaee88c2 4961 48e7 Aefb 86f1710bc60f 06)
Label of Tobramycin Inhalation Solution, USP 300 mg/5 mL in a single-dose plastic vial. The label includes space for expiration date and lot number. Product is indicated for respiratory (inhalation) use and is manufactured by Lifestar Pharma LLC.*
FDA Label Image

Instructions For Use Figure D (Aaee88c2 4961 48e7 Aefb 86f1710bc60f 07)

Instructions For Use Figure D (Aaee88c2 4961 48e7 Aefb 86f1710bc60f 07)
An instructional diagram showing the assembly of a nebulizer device with labeled parts: Nebulizer Top, Nebulizer Cup, Mouthpiece, Inspirtory Valve Cap, and Tubing. The illustration depicts hands placing the nebulizer top onto the nebulizer cup.*
FDA Label Image

Instructions For Use Figure E (Aaee88c2 4961 48e7 Aefb 86f1710bc60f 08)

Instructions For Use Figure E (Aaee88c2 4961 48e7 Aefb 86f1710bc60f 08)
An instructional illustration showing how to insert a Nebulizer Insert into a Nebulizer Cup. The diagram includes labeled parts and arrows indicating the direction to place the insert into the cup, with hands depicted performing the actions.*
FDA Label Image

Instructions For Use Figure F (Aaee88c2 4961 48e7 Aefb 86f1710bc60f 09)

Instructions For Use Figure F (Aaee88c2 4961 48e7 Aefb 86f1710bc60f 09)
An instructional illustration showing components labeled 'Nebulizer Cup' and 'Top' placed on a surface labeled 'Clean paper or cloth towels.' The diagram depicts parts presumably related to respiratory inhalation drug administration equipment.*
FDA Label Image

Instructions For Use Figure G (Aaee88c2 4961 48e7 Aefb 86f1710bc60f 10)

Instructions For Use Figure G (Aaee88c2 4961 48e7 Aefb 86f1710bc60f 10)
An instructional illustration depicting a hand placing a dose of medication into a device labeled 'Pulmo Aide,' which is a type of nebulizer used to administer respiratory inhalation solutions.*
FDA Label Image

Instructions For Use Figure H (Aaee88c2 4961 48e7 Aefb 86f1710bc60f 11)

Instructions For Use Figure H (Aaee88c2 4961 48e7 Aefb 86f1710bc60f 11)
An instructional illustration showing a hand unplugging a two-prong electrical plug from a standard electrical outlet. An arrow points away from the outlet, indicating the direction to pull the plug.*
FDA Label Image

Instructions For Use Figure I (Aaee88c2 4961 48e7 Aefb 86f1710bc60f 12)

Instructions For Use Figure I (Aaee88c2 4961 48e7 Aefb 86f1710bc60f 12)
Instructional illustration showing hands opening a unit dose vial labeled Tobramycin Inhalation Solution USP 300 mg/5 mL. The diagram emphasizes pulling the bottom tab to open the vial for respiratory inhalation use.*
FDA Label Image

Instructions For Use Figure J (Aaee88c2 4961 48e7 Aefb 86f1710bc60f 13)

Instructions For Use Figure J (Aaee88c2 4961 48e7 Aefb 86f1710bc60f 13)
An instructional illustration showing a hand squeezing a drop from a Tobramycin solution vial into the top opening of a respiratory inhalation device. The image demonstrates how to properly add the medication solution to the inhaler apparatus for inhalation administration.*
FDA Label Image

Instructions For Use Figure K (Aaee88c2 4961 48e7 Aefb 86f1710bc60f 14)

Instructions For Use Figure K (Aaee88c2 4961 48e7 Aefb 86f1710bc60f 14)
An instructional diagram illustrating the components and assembly of a nebulizer, including the nebulizer top with a semi-circle and stem, nebulizer cup, and nebulizer outlet. The image shows the nebulizer top being inserted and rotated onto the nebulizer cup.*
FDA Label Image

Instructions For Use Figure L (Aaee88c2 4961 48e7 Aefb 86f1710bc60f 15)

Instructions For Use Figure L (Aaee88c2 4961 48e7 Aefb 86f1710bc60f 15)
An instructional diagram showing assembly of a respiratory nebulizer device for inhalation. The image labels the mouthpiece, nebulizer outlet, and nebulizer cup, illustrating how the mouthpiece connects to the outlet on the nebulizer cup.*
FDA Label Image

Instructions For Use Figure M (Aaee88c2 4961 48e7 Aefb 86f1710bc60f 16)

Instructions For Use Figure M (Aaee88c2 4961 48e7 Aefb 86f1710bc60f 16)
An instructional diagram showing the placement of the Inspiratory Valve Cap on a respiratory inhalation device, likely related to Tobramycin solution. Arrows indicate the cap being aligned and placed on top of the device.*
FDA Label Image

Instructions For Use Figure N (Aaee88c2 4961 48e7 Aefb 86f1710bc60f 17)

Instructions For Use Figure N (Aaee88c2 4961 48e7 Aefb 86f1710bc60f 17)
An instructional diagram illustrating assembly of a respiratory inhalation device. The image shows the main body with air intake indicated by an arrow, and an arrow pointing upwards to a nozzle or connector piece being attached to the bottom of the device.*
FDA Label Image

Instructions For Use Figure O (Aaee88c2 4961 48e7 Aefb 86f1710bc60f 18)

Instructions For Use Figure O (Aaee88c2 4961 48e7 Aefb 86f1710bc60f 18)
An instructional illustration showing a hand pressing a button or switch on a device labeled 'Pulmo Aide,' likely demonstrating its operation or usage.*
FDA Label Image

Instructions For Use Figure P (Aaee88c2 4961 48e7 Aefb 86f1710bc60f 19)

Instructions For Use Figure P (Aaee88c2 4961 48e7 Aefb 86f1710bc60f 19)
An instructional illustration showing a medical inhalation device emitting vapor or mist, likely used for administering pulmonary medication such as Tobramycin inhalation solution. The device includes a mouthpiece, handle, and tubing connection.*
FDA Label Image

Instructions For Use Figure Q (Aaee88c2 4961 48e7 Aefb 86f1710bc60f 20)

Instructions For Use Figure Q (Aaee88c2 4961 48e7 Aefb 86f1710bc60f 20)
An instructional illustration showing a person inhaling medication through a device held to the mouth, with a labeled nose clip on the nose to prevent nasal airflow. The diagram demonstrates the correct positioning for respiratory inhalation of a solution.*
FDA Label Image

Pouch Label (Aaee88c2 4961 48e7 Aefb 86f1710bc60f 21)

Pouch Label (Aaee88c2 4961 48e7 Aefb 86f1710bc60f 21)
Label for Tobramycin Inhalation Solution USP 300 mg/5 mL by Lifestar Pharma LLC. The label indicates this respiratory inhalation solution is for inhalation use only by nebulizer, preservative-free, available in 4 single-dose 5 mL ampules per pouch. It requires refrigeration and is sterile. The label includes usage and storage details and contact information for Lifestar Pharma LLC.*
FDA Label Image

Carton (Aaee88c2 4961 48e7 Aefb 86f1710bc60f 22)

Carton (Aaee88c2 4961 48e7 Aefb 86f1710bc60f 22)
TOBRAMYCIN Inhalation Solution USP 300 mg/5 mL label for respiratory inhalation. The label indicates a 28-day supply with 56 single-dose 5 mL ampules, packaged as 4 ampules per pouch and 14 pouches per carton. It is for inhalation by nebulizer only, preservative-free, sterile, and requires refrigeration. Manufactured for Lifestar Pharma LLC.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.